Intervention Study to Control High Blood Pressure for Korean American (HBP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00473681
Recruitment Status : Completed
First Posted : May 15, 2007
Last Update Posted : May 7, 2008
Agency for Healthcare Research and Quality (AHRQ)
Information provided by:
Johns Hopkins University

Brief Summary:
The primary objective of the proposed clinical trials is to compare the differential reduction in blood pressure in underserved hypertensive adult Korean American. The study is designed to test the effectiveness of a comprehensive self-help intervention program.

Condition or disease Intervention/treatment Phase
High Blood Pressure Behavioral: Self-Help Intervention Program-High Blood Pressure Not Applicable

Detailed Description:

CVD is the leading cause of mortality among KA. Recent statistics underscoring the high prevalence and impact of uncontrolled HBP upon this population warrant the development and implementation of effective intervention. KA experiences a great deal of social isolation, which makes it more difficult for them to make behavioral changes for health improvement. individual, family, and community behaviors are part of the HBP problem and also constitute major part of the solution. The proposed research is designed to investigate these issues in a KA population and to lay the groundwork for community-based self-help health education interventions to enhance appropriate care and BP control.

Comparison(s):This community-based self-help intervention approach offers a more culturally appropriate approach to closing the health status gap for KA. Incorporating a partnership with community leaders and health and human service care providers, this approach will utilize state-of-the-art health education strategies and a well-trained bilingual nurse from the community.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 445 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Treatment
Official Title: High Blood Pressure Care for Korean Americans
Study Start Date : September 2003
Actual Primary Completion Date : August 2006
Actual Study Completion Date : August 2007

Primary Outcome Measures :
  1. Blood Pressure, Health-Related Quality of Life(Medical outcome Study Short Form-36) [ Time Frame: Baseling, 12month, 24month ]

Secondary Outcome Measures :
  1. Self-Care Behaviors of HBP Control(Hill-Bone adherence of HBP therapy scale) Enabling Skills(problem-solving skills, cognitive reframing, belief-in-self) Self-Help(Inventory of Adult Role Behaviors) [ Time Frame: Baseline, 3months, 9 months,15 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   40 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Self-identified as first-generation Korean American
  • Age 40 to 65 years of age
  • SBP≥140 or DBP≥90mmHg on HBP medication
  • resident of Greater Baltimore census tracts
  • Written consent to participate in the screening/eligibility visit
  • SBP≥140 or DBP≥90mmHg at the KRC HBP verification visit
  • Written consent to participate in the clinical trial:agreeing to participate in study data collection procedures, receiving HBP education, using HBPMT, and permitting contact with their own medical care provider.

Exclusion Criteria:

  • Acute and/or terminal condition precluding participation such as terminal cancer or acute myocardial infarction
  • Psychiatric diagnosis precluding participation such as schizophrenia and cognitive impairment measured by self-report, chart review, or clinical assessment.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00473681

United States, Maryland
Korean Resource Center
Ellicott city, Maryland, United States, 21042
Sponsors and Collaborators
Johns Hopkins University
Agency for Healthcare Research and Quality (AHRQ)
Principal Investigator: Miyong D Kim, PhD Johns Hopkins university, School of Nursing

Publications of Results:
Other Publications:
Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00473681     History of Changes
Other Study ID Numbers: R01HS013160 ( U.S. AHRQ Grant/Contract )
First Posted: May 15, 2007    Key Record Dates
Last Update Posted: May 7, 2008
Last Verified: May 2008

Additional relevant MeSH terms:
Vascular Diseases
Cardiovascular Diseases